Group One Trading’s Passage Bio PASG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,200
Closed -$17.6K 8892
2025
Q3
$17.6K Buy
2,200
+2,065
+1,530% +$14.4K ﹤0.01% 6797
2025
Q2
$1.08K Sell
135
-255
-65% -$1.86K ﹤0.01% 7544
2025
Q1
$2.75K Buy
390
+135
+53% +$1.46K ﹤0.01% 6886
2024
Q4
$2.89K Buy
255
+245
+2,450% +$3.19K ﹤0.01% 6622
2024
Q3
$140 Buy
+10
New +$159 ﹤0.01% 6462
2024
Q2
Sell
-750
Closed -$20.3K 7283
2024
Q1
$20.3K Buy
750
+275
+58% +$6.62K ﹤0.01% 5405
2023
Q4
$9.6K Buy
+475
New +$6.56K ﹤0.01% 6233
2023
Q2
Sell
-10
Closed -$192 8071
2023
Q1
$192 Sell
10
-15
-60% -$407 ﹤0.01% 6995
2022
Q4
$690 Hold
25
﹤0.01% 6907
2022
Q3
$1K Hold
25
﹤0.01% 7359
2022
Q2
$1K Buy
+25
New +$1.17K ﹤0.01% 7600

Other funds holding PASG

Group One Trading's PASG Position: Q3 2025 in Review

Group One Trading sold out of Passage Bio (PASG) in Q3 2025, closing a stake of 2 shares — an estimated $14 sold.

Group One Trading first reported a position in PASG in Q1 2022 and held it in 14 quarters. The position peaked at $7K in Q1 2022. 32 funds tracked by Wall St. Rank hold PASG as of Q3 2025.

  • Group One Trading reported no remaining Passage Bio position as of Q3 2025 after selling out during the quarter.
  • Group One Trading sold 2 Passage Bio shares in Q3 2025, an estimated $14.
  • Group One Trading first reported a position in Passage Bio in Q1 2022 and held it in 14 quarters.
  • Group One Trading's Passage Bio position peaked at $7K in Q1 2022.
  • 32 funds tracked by Wall St. Rank held Passage Bio as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.